Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations From a Phase 1/2 Trial.
暂无分享,去创建一个
J. Neal | Gregory Riely | D. Costa | P. Janne | A. Tsao | D. Camidge | L. Bazhenova | T. Mekhail | S. Gadgeel | R. Gentzler | Jianchang Lin | J. Patel | A. Spira | H. West | D. Nguyen | Shu Jin | Z. Piotrowska | V. Zhu | Shuanglian Li | V. Bunn | Steven Zhang | S. Vincent